NeuroMetrix Gross Margin vs EBITDA Margin Analysis

NURO Stock  USD 4.16  0.16  4.00%   
Trend analysis of NeuroMetrix balance sheet accounts such as Other Current Liab of 1.9 M provides information on NeuroMetrix's total assets, liabilities, and equity, which is the actual value of NeuroMetrix to its prevalent stockholders. By breaking down trends over time using NeuroMetrix balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

About NeuroMetrix Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of NeuroMetrix at a specified time, usually calculated after every quarter, six months, or one year. NeuroMetrix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of NeuroMetrix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NeuroMetrix currently owns. An asset can also be divided into two categories, current and non-current.

NeuroMetrix Balance Sheet Chart

NeuroMetrix Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how NeuroMetrix uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, NeuroMetrix's Other Stockholder Equity is very stable compared to the past year. As of the 28th of March 2024, Accumulated Other Comprehensive Income is likely to grow to about 227 K, while Common Stock Shares Outstanding is likely to drop about 941.2 K.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of NeuroMetrix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NeuroMetrix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M
 2021 2022 2023 2024 (projected)
Gross Profit5.9M5.8M3.9M3.8M
Total Revenue8.3M8.3M5.9M5.6M

NeuroMetrix fundamental ratios Correlations

0.67-0.2-0.51-0.320.46-0.240.21-0.35-0.19-0.43-0.220.21-0.08-0.210.250.67-0.31-0.08-0.190.110.090.44-0.230.57-0.17
0.67-0.32-0.43-0.420.7-0.15-0.08-0.35-0.37-0.45-0.170.38-0.34-0.30.120.98-0.240.08-0.320.15-0.160.53-0.380.69-0.3
-0.2-0.320.550.630.090.340.180.380.02-0.330.66-0.02-0.25-0.38-0.61-0.320.150.46-0.350.050.670.28-0.28-0.14-0.39
-0.51-0.430.550.870.070.060.080.60.14-0.260.7-0.15-0.31-0.38-0.67-0.510.550.3-0.420.450.610.23-0.32-0.33-0.42
-0.32-0.420.630.87-0.02-0.040.090.810.02-0.160.89-0.03-0.17-0.24-0.58-0.490.670.25-0.30.560.790.12-0.19-0.3-0.3
0.460.70.090.07-0.02-0.110.13-0.25-0.32-0.810.110.33-0.76-0.88-0.540.71-0.310.29-0.90.190.180.89-0.930.48-0.88
-0.24-0.150.340.06-0.04-0.11-0.35-0.06-0.160.2-0.040.15-0.27-0.09-0.25-0.06-0.150.520.07-0.4-0.12-0.180.07-0.31-0.05
0.21-0.080.180.080.090.13-0.35-0.380.14-0.410.11-0.10.37-0.19-0.04-0.09-0.32-0.36-0.220.020.020.35-0.210.52-0.2
-0.35-0.350.380.60.81-0.25-0.06-0.380.040.150.73-0.06-0.110.1-0.27-0.430.810.320.040.60.66-0.180.14-0.460.06
-0.19-0.370.020.140.02-0.32-0.160.140.04-0.05-0.11-1.00.240.190.17-0.460.21-0.10.20.310.05-0.040.2-0.260.21
-0.43-0.45-0.33-0.26-0.16-0.810.2-0.410.15-0.05-0.160.030.560.820.45-0.40.27-0.310.81-0.33-0.39-0.990.82-0.490.8
-0.22-0.170.660.70.890.11-0.040.110.73-0.11-0.160.1-0.15-0.24-0.56-0.240.650.31-0.320.550.720.15-0.22-0.11-0.32
0.210.38-0.02-0.15-0.030.330.15-0.1-0.06-1.00.030.1-0.23-0.2-0.160.46-0.240.08-0.21-0.32-0.050.06-0.220.29-0.22
-0.08-0.34-0.25-0.31-0.17-0.76-0.270.37-0.110.240.56-0.15-0.230.840.73-0.370.1-0.60.8-0.13-0.32-0.640.80.080.82
-0.21-0.3-0.38-0.38-0.24-0.88-0.09-0.190.10.190.82-0.24-0.20.840.81-0.330.29-0.410.98-0.15-0.36-0.870.98-0.210.99
0.250.12-0.61-0.67-0.58-0.54-0.25-0.04-0.270.170.45-0.56-0.160.730.810.09-0.07-0.420.8-0.14-0.51-0.50.760.130.83
0.670.98-0.32-0.51-0.490.71-0.06-0.09-0.43-0.46-0.4-0.240.46-0.37-0.330.09-0.370.07-0.320.0-0.230.49-0.40.66-0.32
-0.31-0.240.150.550.67-0.31-0.15-0.320.810.210.270.65-0.240.10.29-0.07-0.370.030.180.610.52-0.290.27-0.380.21
-0.080.080.460.30.250.290.52-0.360.32-0.1-0.310.310.08-0.6-0.41-0.420.070.03-0.360.250.220.33-0.34-0.23-0.42
-0.19-0.32-0.35-0.42-0.3-0.90.07-0.220.040.20.81-0.32-0.210.80.980.8-0.320.18-0.36-0.24-0.39-0.870.99-0.220.99
0.110.150.050.450.560.19-0.40.020.60.31-0.330.55-0.32-0.13-0.15-0.140.00.610.25-0.240.420.31-0.180.01-0.19
0.09-0.160.670.610.790.18-0.120.020.660.05-0.390.72-0.05-0.32-0.36-0.51-0.230.520.22-0.390.420.35-0.31-0.12-0.38
0.440.530.280.230.120.89-0.180.35-0.18-0.04-0.990.150.06-0.64-0.87-0.50.49-0.290.33-0.870.310.35-0.880.49-0.85
-0.23-0.38-0.28-0.32-0.19-0.930.07-0.210.140.20.82-0.22-0.220.80.980.76-0.40.27-0.340.99-0.18-0.31-0.88-0.260.99
0.570.69-0.14-0.33-0.30.48-0.310.52-0.46-0.26-0.49-0.110.290.08-0.210.130.66-0.38-0.23-0.220.01-0.120.49-0.26-0.19
-0.17-0.3-0.39-0.42-0.3-0.88-0.05-0.20.060.210.8-0.32-0.220.820.990.83-0.320.21-0.420.99-0.19-0.38-0.850.99-0.19
Click cells to compare fundamentals

NeuroMetrix Account Relationship Matchups

NeuroMetrix fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding968.1K3.0M5.1M7.8M1.0M941.2K
Total Assets6.9M8.0M24.9M24.7M21.4M17.5M
Other Current Liab2.1M1.5M853.2K589.9K1.2M1.9M
Total Current Liabilities3.4M2.3M1.4M1.1M1.2M1.2M
Total Stockholder Equity2.5M5.2M23.2M23.4M20.1M14.4M
Property Plant And Equipment Net1.4M876.2K673.9K536.2K543.6K599.7K
Net Debt(2.2M)(4.8M)(22.3M)(3.9M)(1.5M)(1.6M)
Retained Earnings(194.8M)(196.9M)(199.2M)(203.6M)(210.1M)(220.6M)
Accounts Payable725.7K142.3K284.0K368.1K215.5K204.7K
Cash3.1M5.2M22.6M4.3M1.7M1.6M
Non Current Assets Total1.5M904.7K700.3K562.6K570.0K541.5K
Non Currrent Assets Other74.9K29.7K28.5K26.4K30.4K31.9K
Other Assets30.3K29.7K721.2K700.3K630.3K600.4K
Cash And Short Term Investments3.1M5.2M22.6M21.2M18.0M12.0M
Net Receivables488.0K334.3K310.8K646.8K518.8K492.9K
Common Stock Total Equity271.0738.0140.0379.0341.1669.34
Liabilities And Stockholders Equity6.9M8.0M24.9M24.7M21.4M17.5M
Non Current Liabilities Total916.7K461.4K306.7K207.5K92.5K87.9K
Inventory1.2M1.1M706.6K1.6M1.6M1.6M
Other Current Assets2.3M1.9M1.6M2.9M779.0K740.1K
Other Stockholder Equity197.3M202.1M222.4M226.9M230.0M241.5M
Total Liab4.4M2.7M1.7M1.3M1.3M1.3M
Property Plant And Equipment Gross1.4M183.5K2.0M1.2M1.3M926.1K
Total Current Assets5.4M7.1M24.2M24.1M20.9M15.7M
Accumulated Other Comprehensive Income(1.1M)(1.2M)(1.2M)240.2K216.2K227.0K
Common Stock140.0379.0668.0778.0152.0144.4
Property Plant Equipment2.4M273.4K183.5K673.9K606.5K621.0K
Retained Earnings Total Equity(191.3M)(191.0M)(194.8M)(196.9M)(177.2M)(186.1M)
Net Tangible Assets6.1M2.5M5.2M23.2M26.7M28.0M
Capital Surpluse196.4M197.1M197.3M202.1M232.4M201.3M
Net Invested Capital2.5M5.2M23.2M23.4M20.1M13.4M
Net Working Capital2.0M4.8M22.8M23.0M19.6M12.9M
Capital Stock141.0380.0669.0779.0153.0145.35

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.27)
Revenue Per Share
5.664
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.